AGIO
Agios Pharmaceuticals, Inc.
NASDAQ · USHealthcareBiotechnology
$40.06+1.14%
Price as of Jul 20, 2026
AGIO profitability
Agios Pharmaceuticals, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 82.1%
- EBITDA margin
- -633.4%
- EBIT margin
- -720.0%
- Net margin
- -639.8%
- Free cash flow margin
- -582.5%
Returns
- Return on equity
- -38.1%
- Return on assets
- -35.7%
- Return on invested capital
- -41.5%
- Asset turnover
- 0.05x
Cash efficiency
- Cash from operations
- -$380.4M
- Cash per share
- $12
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.